The Department of Disease Control (DDC) has begun administering monkeypox (Mpox) vaccinations to medical personnel.

Mpox is a rare, but potentially serious, viral illness that typically involves flu-like symptoms, swollen lymph nodes and a ...

TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox. TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa ...

The antiviral drug tecovirimat (Tpoxx) didn't accelerate lesion clearance in adults and children with clade 1 mpox participating in a randomized controlled trial in the Democratic Republic of the ...

Mpox can be lethal, especially for children under five years old. The mortality rate for clade I is between 3% and 10%. The ...

The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox and mpox vaccine, live, non-replicating). Prior to this approval, Jynneos had only been ...

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S ...

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.

Early in the morning, the committee considered whether to revise a previous recommendation for Jynneos, the vaccine for mpox, which had sparked a 2022 outbreak that disproportionately affected ...

The new vaccine is a replication-deficient vaccine based on a modified vaccinia Ankara (MVA) strain, similar to Jynneos, the world's first mpox vaccine, developed by Danish company Bavarian Nordic.

There are currently two vaccines including JYNNEOS and ACAM2000 approved by the US Food and Drug Administration (US FDA) for the prevention of mpox and smallpox diseases in adults of 18 years of ...